Potential utility of social media in pharmacovigilance to identify adverse events and safety signals: a scoping review

Social media serves as a relevant complementary source for pharmacovigilance, capturing patient perspectives often missed by spontaneous reporting. However, the consolidation of digital pharmacovigilance requires methodological standardization, rigorous algorithm validation against clinical standards, and specific ethical guidelines for data mining.